Recherche PDF


Cet outil permet de trouver un fichier parmi les documents publics partagés par les utilisateurs de Fichier-PDF.fr.
Dernière mise à jour de la base de données: 27 septembre à 15:26 - Environ 390000 fichiers indexés.

Afficher résultats par page

Réponses pour «acquired»:



Total: 300 résultats - 0.09 secondes

100% - SED 121 SVP Fires California

SED 121 SVP Fires California Sentinel Vision SED-121 16 October 2017 Raging fires around California's Central Valley Sentinel-3 OLCI FR acquired on 09 October 2017 at 18:40:48 UTC Sentinel-3 SLSTR RBT acquired on 09 October 2017 at 18:40:48 UTC Sentinel-3 OLCI FR acquired on 10 October 2017 at 18:14:37 UTC Sentinel-3 SLSTR RBT acquired on 10 October 2017 at 18:14:37 UTC Sentinel-2 MSI (4 tiles) acquired on 12 October 2017 at 18:53:09 UTC Author(s):

fichier-pdf.fr/2017/10/19/sed-121-svp-fires-california/ 19/10/2017

98% - EVT 123 SVP Kamchatka Peninsula

EVT 123 SVP Kamchatka Peninsula Sentinel Vision EVT-123 19 October 2017 2D Layerstack Kamchatka Peninsula Sentinel-2 MSI acquired on 13 May 2017 at 00:36:11 UTC Sentinel-2 MSI acquired on 06 September 2017 at 00:56:41 UTC Sentinel-2 MSI acquired on 07 September 2017 at 00:26:11 UTC Sentinel-3 OLCI FR acquired on 08 September 2017 at 00:07:41 UTC Sentinel-2 MSI acquired on 30 September 2017 at 00:36:01 UTC Sentinel-1 CSAR IW acquired on 04 October 2017 at 07:08:10 UTC Sentinel-1 CSAR IW acquired on 04 October 2017 at 07:08:39 UTC Sentinel-1 CSAR IW acquired on 05 October 2017 at 19:39:25 UTC Author(s):

fichier-pdf.fr/2017/10/19/evt-123-svp-kamchatka-peninsula/ 19/10/2017

92% - SED 124 SVP Hurricane Ophelia

SED 124 SVP Hurricane Ophelia Sentinel Vision SED-124 20 October 2017 Hurricane Ophelia Sentinel-3 SLSTR RBT acquired on 12 October 2017 at 12:19:18 UTC Sentinel-1 CSAR IW acquired on 16 October 2017 at 06:38:21 UTC Sentinel-3 SLSTR RBT acquired on 16 October 2017 at 10:31:34 UTC Author(s):

fichier-pdf.fr/2017/10/19/sed-124-svp-hurricane-ophelia/ 19/10/2017

91% - Mentor profile Booklet

During her gap year, she acquired her first M&A experience in Deloitte through a 6-month internship and kept working on it for another 6 months in BNP Paribas.

fichier-pdf.fr/2014/01/20/mentor-profile-booklet/ 20/01/2014

87% - Mentor profile Booklet

During her gap year, she acquired her first M&A experience in Deloitte through a 6-month internship and kept working on it for another 6 months in BNP Paribas.

fichier-pdf.fr/2014/01/23/mentor-profile-booklet/ 23/01/2014

86% - AION Patch Notes 1 5

Abyss Points acquired or deducted through PvP victory and defeat have been adjusted.

fichier-pdf.fr/2014/03/15/aion-patch-notes-1-5/ 15/03/2014

84% - Syncro

He has acquired some experience thanks to his participation in many events, ladders, cups including the qualification cup for the ESL Major Series, the EPS playoffs and various LAN-parties and also to his former teammates, some of which evolved as national players.

fichier-pdf.fr/2011/07/07/syncro/ 07/07/2011

84% - CV DAHMEN WAJDI

Achievement oriented IT and management seeking to leverage extensive background in IT, consultancy and marketing with a large company whereby can fully use and develop my acquired skills and competence.

fichier-pdf.fr/2012/11/13/cv-dahmen-wajdi/ 13/11/2012

83% - cover letterIMB

Your company would provide me with the best possible opportunity to apply the skills I have already acquired and develop new ones.

fichier-pdf.fr/2016/08/22/cover-letterimb/ 22/08/2016

83% - SED 122 SVP Wageningen Netherlands

SED 122 SVP Wageningen Netherlands Sentinel Vision SED-122 18 October 2017 Wageningen, Netherlands Sentinel-2 MSI acquired on 14 August 2017 at 10:50:31 UTC Sentinel-1 CSAR IW acquired on 10 September 2017 at 05:50:05 UTC Author(s):

fichier-pdf.fr/2017/10/19/sed-122-svp-wageningen-netherlands/ 19/10/2017

82% - TERMS OF USE

By their order, the User Customer acquires a share of common ownership in the Art Work, alongside other User Customers who have acquired a similar share of common ownership on the same Art Work.

fichier-pdf.fr/2018/07/30/terms-of-use/ 30/07/2018

80% - BILINGUISME ET VIEILLISSEMENT

Our results suggest a positive effect of bilingualism on later-life cognition, including in those who acquired their second language in adulthood.

fichier-pdf.fr/2014/07/01/bilinguisme-et-vieillissement/ 01/07/2014

77% - tildren insertion prox susp

inversion time [TI], 120 msec), which uses a fat suppression technique, were acquired in the transverse and sagittal planes.

fichier-pdf.fr/2019/02/02/tildren-insertion-prox-susp/ 02/02/2019

77% - INTERN. ESCROCS

Has the land already been acquired?

fichier-pdf.fr/2016/03/10/intern-escrocs/ 10/03/2016

76% - Recommandation letters eng

Thank you for your attention for her candidature, please accept my devotion SIRET N°81779610500028 Madam Daphnée DUPRE de BOULOIS 3 rue Lebreton 44400 REZE Saint Herblain, the 08/01/2017 CERTIFICATE OF ACQUIRED SKILLS AND HUMAN QUALITIES DEVELOPED I, the undersigned, Frédéric de BOULOIS, manager of the Bar Brasserie SAVEURS &

fichier-pdf.fr/2017/02/06/recommandation-letters-eng/ 06/02/2017

74% - AION Patch Notes 3 5

- Existing Abyss siege quests can no longer be acquired.

fichier-pdf.fr/2014/03/15/aion-patch-notes-3-5/ 15/03/2014

74% - Past experience

Importantly, this implies an ongoing relationship between early-established neural representations and more complex, higher level abilities that are acquired years or even decades later.

fichier-pdf.fr/2016/04/18/past-experience/ 18/04/2016

72% - The Vaccine Adverse Event Reporting System (VAERS) Results Form (1)

The Vaccine Adverse Event Reporting System (VAERS) Results Form (1) 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form CDC WONDER FAQs Help Contact Us WONDER Search The Vaccine Adverse Event Reporting System (VAERS) Results Year Died Vaccine Type ABDOMEN SCAN 2021 COVID19 VACCINE (COVID19) ABDOMEN SCAN 2021 Symptoms Total ABDOMEN SCAN ABDOMINAL DISCOMFORT 2021 ABDOMINAL DISCOMFORT 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISCOMFORT ABDOMINAL DISTENSION 2021 ABDOMINAL DISTENSION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISTENSION ABDOMINAL EXPLORATION 2021 ABDOMINAL EXPLORATION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL EXPLORATION ABDOMINAL HERNIA 2021 ABDOMINAL HERNIA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL HERNIA ABDOMINAL INJURY 2021 ABDOMINAL INJURY 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL INJURY ABDOMINAL MASS 2021 ABDOMINAL MASS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL MASS ABDOMINAL PAIN 2021 ABDOMINAL PAIN 2021 ABDOMINAL PAIN Unknown Date ABDOMINAL PAIN Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN ABDOMINAL PAIN LOWER 2021 ABDOMINAL PAIN LOWER 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN LOWER ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER Unknown Date ABDOMINAL PAIN UPPER Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN UPPER ABDOMINAL SEPSIS 2021 ABDOMINAL SEPSIS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL SEPSIS ABDOMINAL TENDERNESS 2021 ABDOMINAL TENDERNESS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL TENDERNESS ABDOMINAL WALL HAEMATOMA 2021 ABDOMINAL WALL HAEMATOMA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMATOMA ABDOMINAL WALL HAEMORRHAGE 2021 ABDOMINAL WALL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMORRHAGE ABDOMINAL WALL OEDEMA Total 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 29 0.42% 29 0.42% 29 0.42% 26 0.37% 26 0.37% 26 0.37% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 115 1.65% 115 1.65% 3 0.04% 3 0.04% 118 1.69% 11 0.16% 11 0.16% 11 0.16% 57 0.82% 57 0.82% 5 0.07% 5 0.07% 62 0.89% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms ABDOMINAL WALL OEDEMA Year Died Vaccine Type Total 2021 Total ABDOMINAL WALL OEDEMA ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY Unknown Date ABDOMINAL X-RAY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL X-RAY ABNORMAL BEHAVIOUR 2021 ABNORMAL BEHAVIOUR 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL BEHAVIOUR ABNORMAL FAECES 2021 ABNORMAL FAECES 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL FAECES ABNORMAL SLEEP-RELATED EVENT 2021 ABNORMAL SLEEP-RELATED EVENT 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL SLEEP-RELATED EVENT ABSCESS DRAINAGE 2021 ABSCESS DRAINAGE 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS DRAINAGE ABSCESS LIMB 2021 ABSCESS LIMB 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS LIMB ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 COVID19 VACCINE (COVID19) Total Total ABSENCE OF IMMEDIATE TREATMENT RESPONSE ABSTAINS FROM ALCOHOL 2021 ABSTAINS FROM ALCOHOL 2021 COVID19 VACCINE (COVID19) Total Total ABSTAINS FROM ALCOHOL ACCIDENT 2021 ACCIDENT 2021 COVID19 VACCINE (COVID19) Total Total ACCIDENT ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE Unknown Date ACCIDENTAL OVERDOSE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACCIDENTAL OVERDOSE ACIDOSIS 2021 ACIDOSIS 2021 COVID19 VACCINE (COVID19) Total Total ACIDOSIS ACQUIRED OESOPHAGEAL WEB 2021 ACQUIRED OESOPHAGEAL WEB 2021 COVID19 VACCINE (COVID19) Total Total ACQUIRED OESOPHAGEAL WEB ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 7 0.10% 7 0.10% 4 0.06% 4 0.06% 11 0.16% 29 0.42% 29 0.42% 29 0.42% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 6 0.09% 6 0.09% 6 0.09% 1 0.01% 1 0.01% 1 0.01% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 19 0.27% 19 0.27% 19 0.27% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 7 0.10% 7 0.10% 2/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms Year Died ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED Vaccine Type Total ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN 2021 ACUTE ABDOMEN 2021 COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT Unknown Date ACUTE CARDIAC EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE CARDIAC EVENT ACUTE CHEST SYNDROME 2021 ACUTE CHEST SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CHEST SYNDROME ACUTE CORONARY SYNDROME 2021 ACUTE CORONARY SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CORONARY SYNDROME ACUTE HEPATIC FAILURE 2021 ACUTE HEPATIC FAILURE 2021 COVID19 VACCINE (COVID19) Total Total ACUTE HEPATIC FAILURE ACUTE INTERSTITIAL PNEUMONITIS 2021 ACUTE INTERSTITIAL PNEUMONITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE INTERSTITIAL PNEUMONITIS ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY Unknown Date ACUTE KIDNEY INJURY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE KIDNEY INJURY ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE Unknown Date ACUTE LEFT VENTRICULAR FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE LEFT VENTRICULAR FAILURE ACUTE MYELOID LEUKAEMIA 2021 ACUTE MYELOID LEUKAEMIA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE MYELOID LEUKAEMIA ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION Unknown Date ACUTE MYOCARDIAL INFARCTION Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE MYOCARDIAL INFARCTION ACUTE PULMONARY OEDEMA 2021 ACUTE PULMONARY OEDEMA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE PULMONARY OEDEMA ACUTE RESPIRATORY DISTRESS SYNDROME 2021 ACUTE RESPIRATORY DISTRESS SYNDROME 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 7 0.10% 10 0.14% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 1 0.01% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 2 0.03% 2 0.03% 2 0.03% 9 0.13% 9 0.13% 9 0.13% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 267 3.82% 267 3.82% 9 0.13% 9 0.13% 276 3.95% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 9 0.13% 9 0.13% 9 0.13% 104 1.49% 104 1.49% 5 0.07% 5 0.07% 109 1.56% 4 0.06% 4 0.06% 4 0.06% 64 0.92% 64 0.92% 3/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date COVID19 VACCINE (COVID19) ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date Symptoms Total Total ACUTE RESPIRATORY DISTRESS SYNDROME ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE Unknown Date ACUTE RESPIRATORY FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE RESPIRATORY FAILURE ACUTE SINUSITIS 2021 ACUTE SINUSITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE SINUSITIS ADAMTS13 ACTIVITY NORMAL 2021 ADAMTS13 ACTIVITY NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ADAMTS13 ACTIVITY NORMAL ADENOCARCINOMA 2021 ADENOCARCINOMA 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA ADENOCARCINOMA METASTATIC 2021 ADENOCARCINOMA METASTATIC 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA METASTATIC ADENOCARCINOMA OF COLON 2021 ADENOCARCINOMA OF COLON 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA OF COLON ADENOVIRUS TEST 2021 ADENOVIRUS TEST 2021 COVID19 VACCINE (COVID19) Total Total ADENOVIRUS TEST ADJUSTED CALCIUM 2021 ADJUSTED CALCIUM 2021 COVID19 VACCINE (COVID19) Total Total ADJUSTED CALCIUM ADRENAL HAEMORRHAGE 2021 ADRENAL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ADRENAL HAEMORRHAGE ADULT FAILURE TO THRIVE 2021 ADULT FAILURE TO THRIVE 2021 COVID19 VACCINE (COVID19) Total Total ADULT FAILURE TO THRIVE ADVERSE DRUG REACTION Unknown Date ADVERSE DRUG REACTION Unknown Date COVID19 VACCINE (COVID19) Total Total ADVERSE DRUG REACTION ADVERSE EVENT 2021 ADVERSE EVENT 2021 ADVERSE EVENT Unknown Date ADVERSE EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT ADVERSE EVENT FOLLOWING IMMUNISATION 2021 ADVERSE EVENT FOLLOWING IMMUNISATION 2021 COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT FOLLOWING IMMUNISATION ADVERSE REACTION Unknown Date ADVERSE REACTION Unknown Date ADVERSE REACTION https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Total Events Reported Percent (of 6,981) 4 0.06% 4 0.06% 68 0.97% 255 3.65% 255 3.65% 4 0.06% 4 0.06% 259 3.71% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 4/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type AFFECT LABILITY 2021 COVID19 VACCINE (COVID19) AFFECT LABILITY 2021 Symptoms Total Total AFFECT LABILITY AGEUSIA 2021 AGEUSIA 2021 AGEUSIA Unknown Date AGEUSIA Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total AGEUSIA AGGRESSION 2021 AGGRESSION 2021 COVID19 VACCINE (COVID19) Total Total AGGRESSION AGITATION 2021 AGITATION 2021 COVID19 VACCINE (COVID19) Total Total AGITATION AGONAL DEATH STRUGGLE 2021 AGONAL DEATH STRUGGLE 2021 COVID19 VACCINE (COVID19) Total Total AGONAL DEATH STRUGGLE AGONAL RESPIRATION 2021 AGONAL RESPIRATION 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RESPIRATION AGONAL RHYTHM 2021 AGONAL RHYTHM 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RHYTHM AIRWAY PATENCY DEVICE INSERTION 2021 AIRWAY PATENCY DEVICE INSERTION 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY PATENCY DEVICE INSERTION AIRWAY SECRETION CLEARANCE THERAPY 2021 AIRWAY SECRETION CLEARANCE THERAPY 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY SECRETION CLEARANCE THERAPY ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE Unknown Date ALANINE AMINOTRANSFERASE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE ALANINE AMINOTRANSFERASE DECREASED 2021 ALANINE AMINOTRANSFERASE DECREASED 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE DECREASED ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED Unknown Date ALANINE AMINOTRANSFERASE INCREASED Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE INCREASED ALANINE AMINOTRANSFERASE NORMAL 2021 ALANINE AMINOTRANSFERASE NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE NORMAL ALBUMIN GLOBULIN RATIO 2021 ALBUMIN GLOBULIN RATIO 2021 COVID19 VACCINE (COVID19) Total Total ALBUMIN GLOBULIN RATIO ALBUMIN GLOBULIN RATIO ABNORMAL 2021 ALBUMIN GLOBULIN RATIO ABNORMAL 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 25 0.36% 9 0.13% 9 0.13% 9 0.13% 24 0.34% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 1 0.01% 22 0.32% 22 0.32% 22 0.32% 5 0.07% 5 0.07% 5 0.07% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 4 0.06% 2 0.03% 2 0.03% 2 0.03% 38 0.54% 38 0.54% 1 0.01% 1 0.01% 39 0.56% 17 0.24% 17 0.24% 17 0.24% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0 01% 5/179

fichier-pdf.fr/2021/09/28/the-vaccine-adverse-event-reporting-system-vaers-results-form-1/ 28/09/2021

72% - Manual

If you acquired this product in France, this agreement is governed by the French laws.

fichier-pdf.fr/2010/08/12/m6y8frw/ 12/08/2010

71% - Resume Colloque Taza (Mamadou Lamine NDIAYE and al.)

Remote sensing data acquired at medium spatial resolution (MSR) constitute an important source of information for the monitoring of land cover changes.

fichier-pdf.fr/2016/08/31/resume-colloque-taza-mamadou-lamine-ndiaye-and-al/ 31/08/2016

70% - Lucas DELONGEAS China Expatriation LingnanUniversity

Professional and technical acquired skills – Personal development ......................................13 4.4.

fichier-pdf.fr/2017/12/10/lucas-delongeas-china-expatriation-lingnanuniversity/ 10/12/2017

69% - European MA Report 2019 v2

1,400 800 8000 600 6000 400 4000 200 2000 0 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Most active countries in Continental Europe by deal volume 2018 1600 1400 1200 1000 800 600 400 200 0 European M&A Drilling down, just over 53% of all European transactions in 2018 were traditional acquisitions, with a further 16% involving early-stage development capital investments and 12% seeing shares acquired via a capital increase or rights issue.

fichier-pdf.fr/2019/02/19/european-ma-report-2019-v2/ 19/02/2019

68% - chapitre tax rapport OBG 2016 (1)

and • For the calculation of the sale gain, the acquisition cost and the rental of the property acquired under an IMB contract must be taken into consideration.

fichier-pdf.fr/2016/11/10/chapitre-tax-rapport-obg-2016-1/ 10/11/2016

67% - Guide de bonnes pratiques PHC DREIC 2015

Rights acquired outside the framework of collaborative research Rights acquired prior to or at the same time as collaborative research between the Parties shall remain the property of the Parties.

fichier-pdf.fr/2015/01/27/guide-de-bonnes-pratiques-phc-dreic-2015/ 27/01/2015

66% - researchMasquidaPhD

Skills that will be acquired in the course the PhD:

fichier-pdf.fr/2017/08/24/researchmasquidaphd/ 24/08/2017